Financial Performance - The net loss for the nine months ended September 30, 2025, was $134,658, compared to a net income of $215,882 for the same period in 2024[13]. - For the three months ended September 30, 2025, the net loss was $56,580, compared to a net loss of $64,743 for the same period in 2024, indicating an improvement of approximately 12.5%[71]. - The basic and diluted net loss per ordinary share for the three months ended September 30, 2025, was $0.11, while for the same period in 2024, it was $(0.01)[71]. - The basic and diluted net income per ordinary share for the nine months ended September 30, 2025, was $0.32, compared to $(0.04) for the same period in 2024[71]. - Cash used in operating activities for the nine months ended September 30, 2025, was $313,564, with a net loss of $134,658[142]. - The Company reported general and administrative expenses of $78,428, compared to $195,662 for the same period in 2024, reflecting a decrease of approximately 60%[115]. Assets and Liabilities - As of September 30, 2025, total assets amounted to $654,159, compared to $4,642,664 as of December 31, 2024, indicating a significant decrease[11]. - Current liabilities increased to $662,357 from $437,719 in the previous period, primarily due to an increase in accounts payable and accrued expenses[11]. - As of September 30, 2025, the accumulated deficit increased to $(7,530,490) from $(7,280,411) at the end of 2024[11]. - As of September 30, 2025, the Company had cash of $50,633 and a working capital deficit of $530,490[50]. - As of September 30, 2025, there was $293,054 outstanding under the 2024 Note and July 2025 Note combined[85]. - The Company had cash of $50,633 outside the Trust Account as of September 30, 2025, with a working capital deficit of $530,490[148]. IPO and Financing - The IPO generated gross proceeds of $200,000,000 from the sale of 20,000,000 units at an offering price of $10.00 per unit[21]. - Transaction costs for the IPO totaled $13,150,218, including $3,380,000 in underwriting fees and $7,000,000 in deferred underwriting fees[22]. - The Company completed an IPO of 20,000,000 units at an offering price of $10.00 per unit, generating gross proceeds of $200,000,000[139]. - A Private Placement of 8,966,000 warrants was executed at $1.00 per warrant, resulting in total proceeds of $8,966,000[140]. - The Sponsor agreed to loan the Company up to $160,000 on December 9, 2024, and up to $152,000 on July 14, 2025, for working capital purposes[40]. - The Sponsor agreed to loan the Company up to $500,000 under a non-interest bearing promissory note for working capital purposes[48]. Business Operations - The company had not commenced any operations as of September 30, 2025, and all activities were related to its formation and search for a business combination target[20]. - The Company has not generated any operating revenues and will only do so after completing its initial business combination[20]. - The Company expects to incur significant costs related to being a public company and for due diligence expenses in connection with searching for a Business Combination[136]. - The Company has until August 5, 2027, to consummate a Business Combination, or it will trigger an automatic winding up and liquidation[148]. - The Company has not experienced losses on cash accounts exceeding the FDIC limit of $250,000 as of September 30, 2025[60]. Shareholder and Governance - Following the Share Exchange on December 7, 2023, the Sponsor held approximately 68.1% of the Company's outstanding Class A ordinary shares[36]. - The Company filed an Information Statement on July 15, 2025, notifying shareholders of a change in the majority of the board of directors[41]. - On July 28, 2025, Yip Tsz Yan was appointed as Chief Executive Officer, Chief Financial Officer, and Chairman of the Board[42]. - The Company’s shareholders approved an extension to consummate a business combination until August 5, 2027, during the extraordinary general meeting held on July 30, 2025[130]. Market and Trading - The Company received a Delisting Letter from Nasdaq on September 13, 2024, due to non-compliance with the minimum 400 total shareholders requirement[38]. - Trading in the Company's securities was suspended on Nasdaq on September 24, 2024, and is now quoted on OTC markets[39]. - The Company’s securities were suspended from trading on Nasdaq on September 24, 2024, and are now quoted in the Over-the-Counter market[124]. Accounting and Compliance - The Company engaged FundCertify CPA Professional Corporation as its independent registered public accounting firm for the fiscal year ending December 31, 2025[47]. - The Company is classified as an "emerging growth company" under the JOBS Act, allowing it to delay compliance with new financial accounting standards[55]. - The Company adopted ASU 2023-09 effective January 1, 2025, which did not impact its financial position or results of operations[75]. - The Company has no off-balance sheet financing arrangements as of September 30, 2025[150].

Financial Performance - The company reported a net loss of $17,335 for the three months ended June 30, 2025, compared to a net income of $138,280 for the same period in 2024, indicating a significant decline in performance [14]. - For the three months ended June 30, 2025, the net loss was $17,335,000 compared to a net income of $138,280,000 for the same period in 2024 [72]. - For the six months ended June 30, 2025, the net loss was $78,078,000 compared to a net income of $280,625,000 for the same period in 2024 [72]. - The basic and diluted net loss per ordinary share for the three months ended June 30, 2025, was $0.31, while for the same period in 2024, it was $(0.03) [72]. - The basic and diluted net income per ordinary share for the six months ended June 30, 2025, was $0.10, compared to $(0.02) for the same period in 2024 [72]. Assets and Liabilities - As of June 30, 2025, total assets amounted to $4,728,543, an increase from $4,642,664 as of December 31, 2024, representing a growth of approximately 1.85% [12]. - Total current liabilities increased to $601,676 as of June 30, 2025, from $437,719 as of December 31, 2024, marking an increase of about 37.4% [12]. - The accumulated deficit increased to $7,452,710 as of June 30, 2025, from $7,280,411 as of December 31, 2024, indicating a rise of about 2.4% [12]. - As of June 30, 2025, the Company had cash of $147,832 and a working capital deficit of $452,710 [52]. - As of June 30, 2025, the Company held investments in the Trust Account valued at $4,579,577, reflecting a fair value measurement [110]. Business Operations - The company has not commenced any operations as of June 30, 2025, and will not generate operating revenues until after completing its initial Business Combination [23]. - The Company has until August 5, 2027, to consummate a Business Combination, or it will trigger an automatic winding up and liquidation [53]. - The Company has not yet selected a specific Business Combination target and intends to use cash from the IPO and private placement for this purpose [130]. - The company expects to incur significant costs in pursuing its acquisition plans, with no assurance of successful completion of a Business Combination [131]. IPO and Financing - The company raised gross proceeds of $200,000,000 from its IPO, which was completed on May 5, 2022 [24]. - The Company completed its IPO on May 5, 2022, selling 20,000,000 Units at a price of $10.00 per Unit [78]. - The Company raised $203,500,000 from its IPO, with net proceeds placed in a Trust Account for investment in U.S. government securities [27]. - The Sponsor agreed to loan the Company up to $160,000 and $152,000 for working capital purposes, both loans being non-interest bearing [40]. - The Sponsor agreed to loan the Company an aggregate of up to $500,000 for various expenses and working capital purposes [49]. Shareholder Actions - As of August 1, 2023, 18,003,605 Class A ordinary shares were tendered for redemption, with a total redemption value of $190,703,967 [34]. - On July 30, 2025, shareholders approved an extension of the deadline to August 5, 2027, providing a total of 63 months from the IPO for a Business Combination [46]. - At the 2025 EGM, shareholders approved the Extension Amendment Proposal, allowing the company to extend the deadline for a business combination to August 5, 2027 [139]. - 344,384 Class A ordinary shares were redeemed for approximately $4,078,485 following the shareholders' vote at the 2025 EGM [140]. Regulatory and Compliance - The Company received a Delisting Letter from Nasdaq on September 13, 2024, due to non-compliance with the minimum 400 total shareholders requirement [38]. - Trading in the Company's securities was suspended on Nasdaq on September 24, 2024, and is now quoted on OTC markets [39]. - The Company engaged FundCertify CPA Professional Corporation as its independent registered public accounting firm for the fiscal year ending December 31, 2025 [48]. - There were no changes in the internal control over financial reporting that materially affected the Company's financial reporting during the most recent fiscal quarter [171]. - The Company is not currently a party to any material litigation or legal proceedings that could materially affect its business or financial condition [173]. Miscellaneous - The Company has provisions for Public Shareholders to redeem shares for a pro rata portion of the Trust Account, initially anticipated at $10.175 per share [28]. - The Company has not experienced losses on cash accounts that may exceed the Federal Depository Insurance Corporation limit of $250,000 [62]. - The Company has not had any dilutive securities that could potentially be exercised or converted into ordinary shares as of June 30, 2025 [71]. - The Company has no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2025 [74]. - The Company is not subject to income taxes in the British Virgin Islands, resulting in a tax provision of zero for the periods presented [75].

Financial Performance - The net loss for the three months ended March 31, 2025, was $60,743, compared to a net income of $142,345 for the same period in 2024[14]. - Interest income for the three months ended March 31, 2025, was $48,035, significantly lower than $290,996 in the prior year[14]. - Basic and diluted net loss per share for Class A and Class B ordinary shares not subject to redemption was $(0.02) for both periods ended March 31, 2025, and 2024[14]. - The net loss including accretion of ordinary shares to redemption value was $107,712 for Q1 2025, compared to a loss of $143,267 in Q1 2024[75]. - The Company had a net loss of $60,743 for the three months ended March 31, 2025, with general and administrative expenses of $108,778 and interest income of $48,035[150]. Assets and Liabilities - As of March 31, 2025, total assets amounted to $4,560,695, a decrease from $4,642,664 as of December 31, 2024[12]. - Current liabilities were $416,493, down from $437,719 as of December 31, 2024, with accounts payable and accrued expenses at $258,655[12]. - Cash at the end of the period was $12,598, a significant decrease from $252,438 at the end of March 2024[20]. - As of March 31, 2025, the accumulated deficit increased to $(7,388,123) from $(7,280,411) as of December 31, 2024[12]. - As of March 31, 2025, the Company had cash of $12,598 and a working capital deficit of $388,123[53]. Business Combination and Operations - The company has not commenced any operations and will not generate operating revenues until after completing its initial Business Combination[23]. - The Company has until August 5, 2027, to consummate a Business Combination, failing which it will trigger an automatic winding up, dissolution, and liquidation[54]. - The Company has not yet selected a specific business combination target and does not expect to generate operating revenue until after the completion of its initial business combination[134]. - The Company expects to incur increased expenses due to being a public company and for due diligence related to searching for a business combination[149]. Shareholder Actions and Amendments - On August 1, 2023, shareholders approved the Second Charter Amendment, allowing the Company to extend the Combination Period to August 5, 2024, with 18,003,605 Class A ordinary shares redeemed for a total value of $190,703,967[35]. - On July 23, 2024, the Third Charter Amendment was approved, extending the deadline for a business combination to August 5, 2025, with 1,608,417 Class A ordinary shares redeemed for a total value of $18,165,082.19[38]. - At the 2025 EGM, shareholders approved the Extension Amendment Proposal to extend the deadline for consummating a business combination by 24 months to August 5, 2027[125]. Loans and Financing - The Sponsor agreed to loan the Company up to $500,000 on October 17, 2025, for various expenses, with the loan being convertible into warrants at $1.00 per warrant[51]. - The Sponsor agreed to loan the Company an aggregate of up to $160,000 on December 9, 2024, and additional loans of $152,000 and $500,000 on July 14, 2025, and October 17, 2025, respectively[53]. - The Sponsor has agreed to loan the Company up to $160,000, $152,000, and $500,000 on different dates for various expenses and working capital purposes[166][167]. IPO and Securities - The IPO generated gross proceeds of $200,000,000 from the sale of 20,000,000 units at $10.00 per unit[24]. - The Company completed an IPO on May 5, 2022, selling 20,000,000 units at $10.00 per unit, generating gross proceeds of $200 million[81]. - The sponsor purchased 8,966,000 private placement warrants at $1.00 each, totaling $8,966,000, which were added to the IPO proceeds held in the Trust Account[82]. - The Company completed a Private Placement of 8,966,000 Private Placement Warrants at $1.00 each, generating total proceeds of $8,966,000[152]. Compliance and Regulatory Issues - The Company received a Delisting Letter from Nasdaq on September 13, 2024, indicating non-compliance with the minimum 400 total shareholders requirement[39]. - Trading in the Company's securities was suspended on Nasdaq on September 24, 2024, with securities now quoted on OTC markets[40]. - The financial statements do not include adjustments that might result from the Company's inability to continue as a going concern[54]. General and Administrative Expenses - General and administrative expenses for the three months ended March 31, 2025, were $108,778, down from $148,651 in the same period of 2024[118]. - The Company incurred significant professional costs to remain publicly traded and requires additional financing, with no current commitments for such financing[54]. - The Company has incurred significant professional costs and transaction costs, requiring additional financing to pursue a business combination[160].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ________________ Commission file number: 001-41372 A SPAC II ACQUISITION CORP. (Exact name of registrant as specified in its charter) British Virgin Islands N/A (S ...

Financial Performance - The net loss for the three months ended September 30, 2024, was $64,743 compared to a net income of $997,013 for the same period in 2023[10]. - Basic and diluted net income per share for Class A ordinary shares subject to possible redemption was $0.11 for the three months ended September 30, 2024, down from $0.13 in the same period of 2023[10]. - The accumulated deficit increased from $(6,680,718) in December 2023 to $(7,168,214) in September 2024, reflecting ongoing losses[9]. - The Company incurred a net loss of $64,743 for the three months ended September 30, 2024, compared to a net income of $997,013 for the same period in 2023[53]. - The total net loss, including the remeasurement of ordinary shares, was $193,725 for the three months ended September 30, 2024, compared to a loss of $282,954 for the same period in 2023[53]. - For the nine months ended September 30, 2024, the Company reported a net income of $215,882, with general and administrative expenses of $497,763 and interest income of $713,645[111]. Assets and Liabilities - Total current assets decreased from $476,636 in December 2023 to $93,002 in September 2024, primarily due to a reduction in cash from $442,147 to $72,752[8]. - Total assets decreased significantly from $22,372,321 in December 2023 to $4,526,983 in September 2024, reflecting a decline in investments held in the Trust Account from $21,895,685 to $4,433,981[8]. - Current liabilities increased from $157,354 in December 2023 to $261,216 in September 2024, indicating a rise in accounts payable and accrued expenses[8]. - The Company had a total shareholders' deficit of $(7,168,214) as of September 30, 2024, compared to $(6,680,718) in December 2023[9]. - As of September 30, 2024, the Company had cash of $72,752 and a working capital deficit of $168,214, with uncertainty regarding the ability to complete a Business Combination by the deadline[36]. IPO and Financing - The Company completed its IPO on May 5, 2022, raising gross proceeds of $200 million from the sale of 20 million units at $10.00 per unit[17]. - Transaction costs for the IPO totaled $13,150,218, including $3,380,000 in underwriting fees and $7,000,000 in deferred underwriting fees[18]. - As of the IPO closing, $203,500,000 was placed in a Trust Account, to be invested in U.S. government securities or money market funds[20]. - The Sponsor purchased 8,966,000 Private Placement Warrants at a price of $1.00 per warrant, totaling $8,966,000[65]. - The underwriters received a cash underwriting discount of $3,380,000 upon the closing of the IPO[76]. - The underwriters are entitled to a deferred fee of $7,000,000, payable only if a Business Combination is completed[126]. Business Combination and Compliance - The company has not commenced any operations as of September 30, 2024, and will not generate operating revenues until after completing a business combination[16]. - The Company has until August 5, 2025, to consummate a Business Combination, after which a mandatory liquidation will occur if not completed[122]. - At the 2023 Extraordinary General Meeting, shareholders approved the extension of the business combination deadline to August 5, 2024, with 18,003,605 Class A ordinary shares redeemed for $190,703,967[28]. - The Company submitted a compliance plan to Nasdaq on April 29, 2024, after receiving a Non-Compliance Letter for not maintaining 400 public holders[31]. - Trading in the Company's securities was suspended on September 24, 2024, due to non-compliance with Nasdaq listing requirements[35]. - The Company received a Nasdaq notice on December 11, 2023, for failing to meet the $50 million market value requirement for continued listing[29]. Risks and Uncertainties - The Company faces substantial doubt about its ability to continue as a going concern if it cannot complete a Business Combination by August 5, 2025[37]. - The impact of the COVID-19 pandemic on the Company's search for a target company for a Business Combination remains uncertain[38]. - The ongoing military actions and economic sanctions may materially affect the Company's ability to consummate a Business Combination[39]. - The Company has significant professional costs related to remaining a publicly held reporting company and may need additional financing to complete its Business Combination[37]. Shareholder Information - Following a Share Exchange on December 7, 2023, there were 7,196,395 Class A ordinary shares and 100,000 Class B ordinary shares outstanding[30]. - The Company redeemed 1,608,417 Class A ordinary shares for $18,165,082 during the extraordinary general meeting on July 23, 2024[106]. - As of September 30, 2024, the Class A ordinary shares subject to possible redemption amounted to $4,433,981[64]. - The Class B Ordinary shares will automatically convert into Class A Ordinary shares at a one-for-one basis upon the initial Business Combination[85]. - There were 20,000,000 Public Rights outstanding as of September 30, 2024[94]. Legal and Regulatory Matters - The Company is currently not subject to any material litigation or legal proceedings that could adversely affect its financial condition[133]. - The Company has identified additional risk factors in its filings, although it is not required to disclose them as a smaller reporting company[134]. - On September 13, 2024, the Company received a Delisting Letter from Nasdaq due to non-compliance with the minimum 400 total shareholders requirement[136]. - The delisting may lead to reduced liquidity and increased volatility for the Company's securities, potentially classifying them as "penny stocks"[137].

Financial Performance - For the three months ended June 30, 2024, the net income was $138,280 compared to $2,271,521 for the same period in 2023, representing a decrease of approximately 93.9%[13] - Interest income for the three months ended June 30, 2024, was $291,730, significantly lower than $2,496,231 for the same period in 2023, indicating a decrease of about 88.3%[13] - The Company reported a net loss of $150,504 for the six months ended June 30, 2024, compared to a net loss of $214,948 for the same period in 2023[62] - The Company’s net income (loss) per share for the six months ended June 30, 2024, was $0.12, compared to a loss of $(0.02) for the same period in 2023[58] Expenses and Liabilities - General and administrative expenses for the three months ended June 30, 2024, were $153,450, down from $224,710 in the same period of 2023, indicating a reduction of about 31.7%[13] - The total liabilities as of June 30, 2024, amounted to $7,198,132, slightly up from $7,157,354 as of December 31, 2023, reflecting an increase of approximately 0.6%[10] - The accumulated deficit increased to $(6,974,489) as of June 30, 2024, compared to $(6,680,718) at the end of 2023, marking a decline of about 4.4%[11] - The total shareholders' deficit as of June 30, 2024, was $(6,974,489), compared to $(6,680,718) as of December 31, 2023, reflecting an increase of approximately 4.4%[11] Cash and Working Capital - The cash balance at the end of the period on June 30, 2024, was $168,597, down from $707,116 at the end of June 30, 2023, representing a decrease of approximately 76.1%[20] - As of June 30, 2024, the Company had cash of $168,597 and a working capital of $25,511[41] - The net cash used in operating activities for the three months ended June 30, 2024, was $(273,550), compared to $(356,721) for the same period in 2023, indicating an improvement of approximately 23.2%[20] IPO and Shareholder Information - The Company raised gross proceeds of $200,000,000 from its IPO by selling 20,000,000 units at an offering price of $10.00 per unit[24] - Transaction costs related to the IPO amounted to $13,150,218, including $3,380,000 in underwriting fees and $7,000,000 in deferred underwriting fees[25] - The Company placed $203,500,000 from the net offering proceeds into a Trust Account, which will be invested in U.S. government securities[27] - On August 1, 2023, shareholders approved an extension for completing a business combination to August 5, 2024, with 18,003,605 Class A ordinary shares redeemed for $190,703,967[35] Business Combination and Compliance - The Company has until August 5, 2025, to complete a Business Combination, failing which a mandatory liquidation will occur[41] - The Company has until August 5, 2025, to complete a Business Combination, but Nasdaq rules require completion within 36 months of the IPO, raising concerns about potential delisting[43] - The Company received a notice from Nasdaq on December 11, 2023, for failing to meet the $50,000,000 market value requirement for continued listing[36] Share Structure and Warrants - Following a Share Exchange on December 7, 2023, there were 7,196,395 Class A ordinary shares and 100,000 Class B ordinary shares outstanding[38] - The basic and diluted weighted average shares outstanding for Class A ordinary shares subject to possible redemption was 1,996,395 for both June 30, 2024, and June 30, 2023[13] - The Class A ordinary shares subject to possible redemption as of June 30, 2024, amount to $22,470,081, reflecting a remeasurement of carrying value[71] - There were 9,999,989 Public Warrants outstanding as of June 30, 2024, with an exercise price of $11.50 per share[92] Risk Factors and Future Outlook - The Company has incurred significant professional costs related to remaining publicly traded and pursuing a Business Combination, raising doubts about its ability to continue as a going concern[42] - The impact of geopolitical events, including the conflict in Ukraine and Israel, may adversely affect the Company's ability to complete a Business Combination[45] - The Company has not experienced losses related to credit risk from cash accounts exceeding the FDIC limit of $250,000 as of June 30, 2024[53] Accounting and Internal Controls - The Company’s financial statements reflect all necessary adjustments for fair presentation, but interim results may not indicate future performance[47] - The company evaluated the effectiveness of its disclosure controls and procedures as of June 30, 2024, concluding they were effective[140] - There were no changes in internal control over financial reporting during the most recent fiscal quarter that materially affected the company's internal control[142] - The Company has not opted out of the extended transition period under the JOBS Act, allowing it to adopt new accounting standards at the same time as private companies[48]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Name of each exchange on which registered Units, each consisting of one Class A ordinary share, with no par value, one-half of one redeemable warrant and one right to receive one-tenth of one Class A ordinary share Title of each class Trading Symbol(s) ASCBU The Nasdaq Global Market Class A ordinary shares, no par value, included as part of the units ASCB The Nasdaq Global Market Redeemable warrants, each whole warrant exercisable for o ...

Financial Position - As of December 31, 2023, the company had $442,147 in cash outside of the Trust Account and a working capital of $319,282[72]. - As of December 31, 2023, the company was not subject to any market or interest rate risk, with net proceeds from the initial public offering invested in U.S. government treasury obligations with a maturity of 180 days or less[145]. Business Combination Challenges - The company has incurred significant professional costs and expects to continue incurring expenses related to remaining publicly traded and initial business combination activities[72]. - If the company cannot complete a business combination by August 5, 2024, it may proceed to voluntary liquidation[72]. - Increased competition among special purpose acquisition companies may lead to higher costs for initial business combinations and a scarcity of attractive targets[73]. - The company may face challenges in completing a business combination with U.S. target companies due to foreign investment regulations and potential CFIUS review[76]. Regulatory Environment - The company does not believe it is required to obtain PRC regulatory approvals for its operations or listing on Nasdaq, but future changes in laws could impose such requirements[85]. - The company may face regulatory actions or sanctions from Chinese authorities if it inadvertently concludes that approvals are not required[88]. - The CSRC and other Chinese regulatory bodies may exert more oversight over overseas offerings, which could affect the company's ability to maintain its Nasdaq listing[90]. - The PRC legal system is based on written statutes, and uncertainties regarding its interpretation and enforcement could materially affect the company[96]. - Recent legislative changes in China may not sufficiently cover all economic activities, leading to potential legal uncertainties for the company[97]. - The absence of treaties for reciprocal recognition and enforcement of foreign judgments between China and the U.S. poses legal risks for the company[94]. Operational Risks - The company’s operations may be significantly affected by changes in PRC government policies and regulations, which could impact its business prospects[80]. - The PRC government has significant control over economic growth and resource allocation, which may impact the company's operations and securities value[100]. - The PRC government has implemented measures to encourage foreign investment, but these measures may change, potentially affecting the company negatively[101]. - China's economy has experienced uneven growth across different regions and sectors, which could impact the company's market performance[99]. - Administrative and court proceedings in China may be protracted, leading to increased costs and resource diversion for the company[98]. - The company faces challenges in conducting investigations or evidence collection within China due to regulatory restrictions[95]. - The company’s majority officers and directors have significant ties to China, making it susceptible to economic and political developments in the region[98].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 British Virgin Islands 001-41372 n/a (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) Name of each exchange on which registered Units, each consisting of one Class A ordinary share, with no par value, one-half of one redeemable warrant and one right to receive one-tenth of one Class A ordinary share Title of each class Trading Symbol(s) ASCBU The Nasdaq Global Market Class A ordin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to______ A SPAC II ACQUISITION CORP. (Exact Name of Registrant as Specified in Charter) | --- | --- | --- | |------------------------------------|------------------ ...